Bambuterol, a bronchodilator prodrug with sustained action, enhances delivery of active drug to the lung.
As exemplified with bambuterol, a bronchodilator prodrug with sustained action, increased therapeutic selectivity can be obtained as a result of altered tissue distribution and pharmacokinetics rather than of increased beta 2-adrenoceptor selectivity.